Key findings: 12 mg dose: Average weight loss of 24.2% of body weight (approximately 58 lbs for a 240 lb individual) 8 mg dose: Average weight loss of 22.8% 4 mg dose: Average weight loss of 17.0% Placebo: Average weight loss of 2.1% Over 90% of participants receiving the 8 mg or 12 mg dose lost at least 10% of body weight Over 75% of participants at the highest dose lost at least 20% of body weight Significant improvements in waist circumference, blood pressure, and lipid profiles were observed across dose groups Phase 2 Trial in Type 2 Diabetes A separate phase 2 trial evaluated retatrutide in adults with type 2 diabetes and obesity (Rosenstock et al., Lancet , 2023)
Growing up, I always wanted to help people, he stressed
Consider Adjustments: If semaglutide is linked to your back pain, your doctor may adjust your dosage or suggest alternative treatments
Recent innovations, such as new subcutaneous injection devices and inhalable formulations, cater to patient preferences for convenience and needle-free options
Compounded medications are not FDA-approved as finished drug products and are prepared through licensed pharmacy channels under individualized prescription.